Location · Arlington, TX
Clinical trials in Arlington, TX
33 recruiting studies have a site in Arlington, and 7 of them accept healthy volunteers.
33 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
ProACT Post-Approval Study
Uromedica
- Location
- Arlington, TX + 13 other US sites
- Eligibility basics
- Ages 50+ · Men only
- RecruitingPhase 3
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Ipsen
- Location
- Arlington, TX + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Arlington, TX + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Merck Sharp & Dohme LLC
- Location
- Arlington, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sanofi
- Location
- Arlington, TX + 30 other US sites
- Eligibility basics
- Ages 60+
- Recruiting
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
MedtronicNeuro
- Location
- Arlington, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Valencia Technologies Corporation
- Location
- Arlington, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie
- Location
- Arlington, TX + 29 other US sites
- Eligibility basics
- Ages 12–63
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Arlington, TX + 91 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Boehringer Ingelheim
- Location
- Arlington, TX + 18 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Amgen
- Location
- Arlington, TX + 54 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Regeneron Pharmaceuticals
- Location
- Arlington, TX + 55 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With…
Ventus Therapeutics U.S., Inc.
- Location
- Arlington, TX + 14 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
EyeBiotech Ltd.
- Location
- Arlington, TX + 66 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Akebia Therapeutics
- Location
- Arlington, TX + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
GlaxoSmithKline
- Location
- Arlington, TX + 10 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
GlaxoSmithKline
- Location
- Arlington, TX + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Novartis Pharmaceuticals
- Location
- Arlington, TX + 22 other US sites
- Eligibility basics
- Ages 18–100
- Recruiting
Ambulatory Long Length URodynamics Evaluation
Bright Uro
- Location
- Arlington, TX + 8 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
Mercator MedSystems, Inc.
- Location
- Arlington, TX + 17 other US sites
- Eligibility basics
- Ages 18–89
- RecruitingPhase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Arlington, TX + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Adverum Biotechnologies, Inc.
- Location
- Arlington, TX + 78 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
AstraZeneca
- Location
- Arlington, TX + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Arlington, TX + 28 other US sites
- Eligibility basics
- Ages 18–70